The study also demonstrated that the characteristic Raman signal of adenine appeared prominently at a peak around 730 cm⁻¹ in both the bacterial suspensions and the surrounding medium, indicating active metabolite release (1). This signal was not detectable using conventional Raman spectroscopy, which emphasizes the importance of using SERS and taking advantage of its enhanced sensitivity (1).
Another key finding from this study was the behavior of the silver and gold nanoparticles. During adenine detection, the silver nanoparticles detected trace levels of adenine under both stress and non-stress conditions, whereas the gold nanoparticles exhibited selective detection primarily under stress conditions (1). This distinction is important because it could prove crucial for future applications aiming to differentiate between stressed and non-stressed bacterial populations.
The differential behavior of Ag-NPs and Au-NPs opens up a path toward more nuanced diagnostics. Gold nanoparticles may offer an advantage in distinguishing actual stress responses, reducing the risk of false positives in clinical analyses (1).
The researchers emphasized the potential of this technology to serve as the basis for developing portable, point-of-care (POC) diagnostic devices. Such tools could revolutionize bacterial identification and accelerate antibiotic susceptibility testing, which is currently a critical need in the face of growing antimicrobial resistance (1,3).
By offering rapid and label-free detection of stress-induced metabolites like adenine, SERS combined with nanoparticle substrates could enable healthcare providers to diagnose infections more accurately and swiftly (1).
What are the next steps in this work?
Based on the results of this study, the research team discusses that future research should focus on optimizing nanoparticle formulations and SERS substrates. Doing so, they argue, will help improve reproducibility and selectivity (1). Future studies are also necessary to better understand the nanoparticle-biomolecule interactions and to confirm the broader applicability of these findings across different bacterial species and stressors (1).
The main goal is to build user-friendly diagnostic platforms that can be deployed in both hospital and field settings. This study is a step in that direction, showcasing how fundamental research in spectroscopy and nanotechnology can translate into real-world healthcare benefits (1). With continued refinement, the technology could play a pivotal role in transforming how bacterial infections are detected, treated, and managed globally.
References
- Ghazalova, M.; Modlitbova, P.; Samek, O.; et al. Surface-Enhanced Raman Spectroscopy for Adenine Detection in Five Selected Bacterial Strains Under Stress Conditions. Sensors 2025, 25 (15), 4629. DOI: 10.3390/s25154629
- Takallu, S.; Aiyelabegan, H. T.; Zomorodi, A. R.; et al. Nanotechnology Improves the Detection of Bacteria: Recent Advances and Future Perspectives. Heliyon 2024, 10 (11), e32020. DOI: 10.1016/j.heliyon.2024.e32020.
- Kerremans, J. J.; Verboom, P.; Stijnen, T.; et a. Rapid Identification and Antimicrobial Susceptibility Testing Reduce Antibiotic Use and Accelerate Pathogen-directed Antibiotic Use. J. Antimicrob. Chemo. 2007, 61 (2), 428–435. DOI: 10.1093/jac/dkm497